Screening and monitoring both get mentioned in these presentations - but its confusing why and how these terms get used.
Clearly they have 2 massively different implications.
For example in breast cancer - Screening is for any woman (to check for incidence) - whilst monitoring is only for those who have been diagnosed (to chart their recovery).
Hugely different addressable markets!!!
Check out the timelines in the decks - only talk about breast and ovarian monitoring.
But elsewhere they mention screening.
On another line in the timeline they mention pan-cancer screening.
Anybody not confused by this?
Screening and monitoring both get mentioned in these...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
-0.040(6.06%) |
Mkt cap ! $57.05M | |||
| Open | High | Low | Value | Volume |
| 67.0¢ | 67.0¢ | 62.0¢ | $83.87K | 129.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 739 | 1 |
View Market Depth
| Last trade - 15.48pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
62.5¢ |
Change
-0.040 ( 3.10 %) |
||||
| Open | High | Low | Volume | ||
| 66.0¢ | 66.5¢ | 62.5¢ | 7536 | ||
| Last updated 15.48pm 17/06/2024 ? | |||||
| IIQ (ASX) Chart |
